Drug Topics
FEBRUARY 20, 2024
Drug Topics sat down with Jude Dieterman, CEO of Outcomes, to discuss the value and uniqueness of the company in the pharmacy market, what’s next on the horizon, and the upcoming event.
PharmaVoice
FEBRUARY 20, 2024
A significant growth is predicted for both AI and IoT in healthcare. By 2030, the AI market is expected to reach $187.95 billion USD, while the IoT market is projected to climb even higher to $312.7 billion USD.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
FEBRUARY 20, 2024
Mental health challenges in the United States were exacerbated by the COVID-19 pandemic, and pharmacists are poised to help pick up the pieces.
PharmaVoice
FEBRUARY 20, 2024
While buzz builds around “off the shelf” CAR-T cell therapies, Kite is staying competitive with a shorter manufacturing turnaround and a focus on broadening applications.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
FEBRUARY 20, 2024
As pharmacies continue their rapid adoption of technological tools to improve efficiency, being prepared for cyberattacks is more important than ever.
STAT
FEBRUARY 20, 2024
Groundbreaking research more than a decade ago showed that almost one-fifth of people enrolled in Medicare were being readmitted within 30 days after being discharged from the hospital, harming patients and increasing costs. That study led to a sea change in health care. The government started closely monitoring readmission rates and imposing fines on hospitals with high rates.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
FEBRUARY 20, 2024
Lynn Cole was in a never-ending cycle of getting recurrent blood infections. And no antibiotic drugs managed to kill off her zombie-like bacteria. “It just got so frustrating over the years because we couldn’t find the source, so we couldn’t figure out how to treat it and prevent it from happening,” said Mya Cole, Lynn’s daughter.
Pharmacy Times
FEBRUARY 20, 2024
Nearly 60% of patients who regained all the weight stayed in remission at 5 years post-surgery, according to study results.
STAT
FEBRUARY 20, 2024
AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July. Gonzalez had previously said he would depart when AbbVie had a plan in place to move on from its best-selling drug, Humira , which is now facing competition from cheaper biosimilars.
Pharmacy Times
FEBRUARY 20, 2024
Community pharmacists are in a unique position to counsel caregivers on liquid children’s products
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
FEBRUARY 20, 2024
An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products. Triple-check your data or we’ll reject your device, the FDA warned. The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance.
Pharmacy Times
FEBRUARY 20, 2024
RSV can exacerbate asthma development by causing damage to the tissue in the airways, promoting inflammation and increasing airway hyper-responsiveness
STAT
FEBRUARY 20, 2024
The federal government’s plan to boost its oversight of the use of artificial intelligence tools in health care drew censure from startups arguing that overregulation stifles new ideas. But as Washington forges ahead, founders say they’re in the dark about who will be regulated and how — and they’re urging policymakers to offer clarity.
Fierce Healthcare
FEBRUARY 20, 2024
As the No Surprises Act took full effect, the number of in-network claims processes grew notably, according to a new analysis from FAIR Health. | As the No Surprises Act took full effect, the number of in-network claims processes grew notably, according to a new analysis from FAIR Health.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
FEBRUARY 20, 2024
WASHINGTON — Drugmakers are doing everything to tap the bottomless well of demand for new obesity drugs , and they might get some government help. The agency that regulates Obamacare insurance is considering a technical change that would require insurers to cover obesity drugs in a market of more than 20 million Americans. Weight loss drugs are a blessing for patients , a boon for drugmakers , and a potentially huge expense for insurers and taxpayers.
Pharmacy Times
FEBRUARY 20, 2024
Datopotamab deruxtecan is an investigational TROP2 directed antibody drug conjugate that showed positive survival impact compared to chemotherapy.
STAT
FEBRUARY 20, 2024
Ring Therapeutics, a gene therapy startup launched by Flagship Pioneering, has laid off just under 20% of its staff, or 19 employees, Flagship confirmed to STAT. The move comes as Sonata Therapeutics, another Flagship startup, has let go of a third of its staff , part of a broader hunkering down by platform companies. As funding for private biotechs remains scarce, startups hoping to develop new technologies — always an expensive, setback-ridden process — have had to make tough cho
Fierce Healthcare
FEBRUARY 20, 2024
MA governor orders Steward Health Care to disclose withheld financial documents, says it must exit state 'as soon as possible' dmuoio Tue, 02/20/2024 - 16:37
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
FEBRUARY 20, 2024
A U.S. appeals court revived a controversial lawsuit brought by nearly two dozen people who claimed they were harmed by a contaminated rare disease medicine sold by a Sanofi subsidiary and a subsequent rationing plan that only worsened their health. And if some upcoming procedural hurdles are cleared, the suit may shine a light on an unusual patient dilemma when a drug is in short supply.
Fierce Healthcare
FEBRUARY 20, 2024
Siftwell Analytics, a company providing insights to community health plans to help improve member outcomes, has secured $5.8 million in the company's first venture capital funding round. | A digital health company built to help community plans utilize their data more efficiently raised nearly $6 million in a recent funding round.
pharmaphorum
FEBRUARY 20, 2024
The FDA has said it plans to deliver a decision in June on the use of Argenx’ Vyvgart Hytrulo in rare autoimmune disease chronic inflammatory demyelinating polyneuropathy (CIDP).
Fierce Healthcare
FEBRUARY 20, 2024
Halfway through its 2024 fiscal year, Ascension has turned its operations around to the tune of about half a billion dollars. | The Catholic giant logged recurring operating margins of 3% for the quarter and 0.3% for the midway point of its current fiscal year.
pharmaphorum
FEBRUARY 20, 2024
Bayer takes anti-alpha2 antiplasmin antibody BAY3018250 into phase 2 as a deep vein thrombosis treatment, hoping to improve on thrombolytics.
STAT
FEBRUARY 20, 2024
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Should ACA plans cover weight loss drugs? Drug makers are doing everything to tap the bottomless well of demand for new obesity drugs — and now, they might get some government help.
pharmaphorum
FEBRUARY 20, 2024
Google DeepMind and Owkin scientists have joined forces to create Bioptimus, an AI startup that aims to develop a foundation model for biology
Fierce Healthcare
FEBRUARY 20, 2024
Accountable care organizations are calling on the feds to increase participation of long-term and post-acute care providers in ACOs and to better incorporate episodic-based payments. | Payers, providers, ACO leaders and advocacy groups convened to discuss how to improve long-term and post-acute care participation in ACOs. These were their recommendations to CMS.
pharmaphorum
FEBRUARY 20, 2024
Patient feedback is driving innovation in next-generation drug delivery devices, improving patient adherence and experience. Learn how these advancements are shaping the future of healthcare.
Fierce Healthcare
FEBRUARY 20, 2024
A year after hitting the pause button on a multi-billion-dollar health tech project at the Department of Veterans Affairs, federal lawmakers continue to have serious concerns about pharmacy softwar | A year after hitting the pause button on a multi-billion-dollar health tech project at the Department of Veterans Affairs, federal lawmakers continue to have serious concerns about pharmacy software issues that could impact patient safety.
The Guardian - Pharmaceutical Industry
FEBRUARY 20, 2024
Governance thinktank asks whether he has earned a hundred times that of many of his employees AstraZeneca’s chief executive, Pascal Soriot , received a pay package of nearly £17m last year, cementing his position as one of the best-paid FTSE 100 bosses as he drew criticism from corporate governance experts. Soriot, who has made nearly £120m in the decade since he took the helm at the drugmaker in October 2012 , was paid £16.9m last year, including salary, benefits and bonuses, up from £15.3m the
Drug Store News
FEBRUARY 20, 2024
Dr. Sashi Moodley, chief medical officer at Walgreens, shares his plans to align medical strategy with the broader retail objectives of the company.
PioneerRx
FEBRUARY 20, 2024
Many pharmacy trends have taken center stage over the last few years. The long-term care at-home model is rapidly gaining traction. Med sync is becoming less of.
STAT
FEBRUARY 20, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The need-to-know this morning Rapt Therapeutics said the FDA placed a clinical hold on its anti-inflammation drug, called zelnecirnon, following a case of liver failure in one patient enrolled in a mid-stage atopic dermatitis study.
Drug Store News
FEBRUARY 20, 2024
The acquisition of Vizio and its SmartCast Operating System would enable Walmart to connect with and serve its customers in new ways.
Expert insights. Personalized for you.
529 
Let's personalize your content